Qureight has raised almost £7 million in Series A funding to accelerate drug development in lung an...
The founder of BenevolentAI is leading a boardroom coup at the high-profile MedTech. Ken Mulvany ...
e-therapeutics plc plans to de-list from the London Stock Exchange’s junior AIM market after slamm...
Presymptom Health has raised £1.5 million in follow-on seed and grant funding that will help accele...
The CTO of BenevolentAI is to leave the MedTech company. Dr Daniel Neil (pictured) joined the com...
Neupulse has secured £2.5 million funding to commercialise the world’s first wearable device to t...
TruSpine Technologies Plc is eyeing a ‘new future’ after shaking up its board and securing poten...
Oxford BioDynamics PLC has raised £9.9 million in a new share placing. The MedTech company, behi...
BenevolentAI's new CEO Dr Joerg Moeller has reported the company's 2023 results. The London-headq...
Manchester-based Phagenesis has raised £33 million in a Series D funding round. The medical devi...
Chancellor Jeremy Hunt has announced a ‘significant’ investment package in the UK’s life scien...
Curve Therapeutics has raised £40.5 million in Series A financing to develop breakthrough cancer tr...